Inside BENEO’s new pulse plant: pioneering sustainable protein from faba beans
Nutrify Today, Pharma Eurasia, and Uzbekistan’s Ministry of Health formalise a structured Indo–CIS corridor, with Pharma Eurasia 2026 (Tashkent, 20–22 May) as the commercial execution platform
In a strategic development set to reshape cross-border healthcare trade between South Asia and Eurasia, the Ministry of Health of the Republic of Uzbekistan has aligned with Nutrify Today and Pharma Eurasia to formalise a structured Indo–CIS pharmaceutical and nutraceutical corridor—positioning Uzbekistan as the region’s premier gateway to the Commonwealth of Independent States (CIS) and the wider Eurasian market.
The trilateral initiative integrates policy facilitation, global industry leadership, and a dedicated commercial exhibition platform—creating a scalable and compliance-driven trade architecture for Indian and global manufacturers seeking structured access into high-growth Eurasian markets.
The commercial activation of this corridor will take place at Pharma Eurasia 2026, scheduled for 20–22 May 2026 in Tashkent, Uzbekistan.
Structured Indo–CIS Corridor: Key Focus Areas
- Regulatory harmonisation and structured bilateral policy dialogue
- Supply chain digitisation and documentation standardisation
- Bilateral investment facilitation and joint venture frameworks
- Clinical research and R&D collaboration
- Institutional trade matchmaking and market commercialisation enablement
Nutrify Today will deploy AI-driven regulatory intelligence and compliance infrastructure to support transparent and scalable cross-border nutraceutical trade.
Abdulla Azizov, First Deputy Minister of Health & Chairman, Pharmaceutical Industry Development Agency, Republic of Uzbekistan says, ““Uzbekistan is poised to emerge as a strategic bridge between India and the CIS in pharmaceuticals and nutraceuticals. Through this collaboration, we are institutionalising a transparent, technology-enabled trade ecosystem that creates lasting value for all stakeholders.”
“With Sumflex anchoring global leadership in Mumbai and Pharma Eurasia providing the structured commercial platform in Tashkent, this initiative transforms vision into executable trade architecture,” mentions, Khasim, MTI Executive Director, Nutrify Today.
“Pharma Eurasia is a structured bridge between global pharmaceutical leadership and high-growth Eurasian markets. Our objective is a long-term, policy-aligned ecosystem where innovation, compliance, and cross-border trade
converge in a sustainable and scalable manner,” opines, M Harikrishnan, Vice President, Tricornio Technologies & Project Director, Pharma Eurasia.
“Uzbekistan is well-positioned to serve as a regional conduit between India and CIS markets. Our engagement with Nutrify Today and Pharma Eurasia embeds transparency and digital tools into a more institutionalised trade and collaboration architecture, while actively welcoming joint-venture cooperation in manufacturing, technology transfer, and regional expansion,” says, Kamila Mirzaeva, Chief International Relations Specialist, Ministry of Health, Republic of Uzbekistan.